Interleukin-17 is a favorable prognostic marker for colorectal cancer

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo et al. · Science · 2006 · 6.5K citations

Medicine, Immunology, Oncology +17

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

Zvi G. Fridlender, Jing Sun, Samuel Kim et al. · Cancer Cell · 2009 · 3.3K citations · Full text

Medicine, Immunology, Oncology +12

NF-κB functions as a tumour promoter in inflammation-associated cancer

Eli Pikarsky, Rinnat M. Porat, Ilan Stein et al. · Nature · 2004 · 2.4K citations

Life Sciences, Cancer Biology, Oncology +16

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

Marie Tosolini, Amos Kirilovsky, Bernhard Mlecnik et al. · Cancer Research · 2011 · 1.1K citations

Life Sciences, Immunology, Oncology +17

Tumor-specific Th17-polarized cells eradicate large established melanoma

Pawel Muranski, Andrea Boni, Paul A. Antony et al. · Blood · 2008 · 830 citations · Full text

Medicine, Immunology, Oncology +12